Hal Barron, MD, who will become CEO and co-chair of Altos Labs. He is now GlaxoSmithKline (GSK)’s President of R&D and Chief Scientific Officer, With $3 billion in capital and an executive team to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results